Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome

Clinical trial NCT05786768 · RECRUITING

Trial details

NCT number: NCT05786768
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Steroid-Dependent Nephrotic Syndrome Steroid-Sensitive Nephrotic Syndrome

Start date: 2023-10-18
Primary completion: 2027-10-18
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.